We are live on ! Find out more
BCMU

BlueCrest Capital Management (UK) Portfolio holdings

AUM $2.66B
1-Year Est. Return 11.87%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+11.87%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$555M
Cap. Flow
+$300M
Cap. Flow %
16.9%
Top 10 Hldgs %
27.58%
Holding
682
New
309
Increased
98
Reduced
45
Closed
186

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$27.3M
2
YELL
Yellow Corporation Common Stock
YELL
+$26M
3
MMM icon
3M
MMM
+$23.3M
4
DVN icon
Devon Energy
DVN
+$15.1M
5
HAL icon
Halliburton
HAL
+$11.8M

Sector Composition

Rank Sector Weight
1 Energy 13.66%
2 Industrials 8.4%
3 Financials 6.44%
4 Healthcare 3.95%
5 Consumer Discretionary 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVN
351
DELISTED
Invensense Inc
INVN
$416K 0.02%
+17,586
New +$368K
DHR icon
352
Danaher
DHR
$141B
$414K 0.02%
8,213
-22,436
-73% -$1.14M
FBIZ icon
353
First Business Financial Services
FBIZ
$603M
$408K 0.02%
+17,300
New +$365K
HNSN
354
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$407K 0.02%
+15,646
New +$351K
CRM icon
355
PUT
Salesforce
CRM
$153B
$400K 0.02%
7,000
HES
356
DELISTED
Hess
HES
$395K 0.02%
4,761
-38,292
-89% -$3.04M
FISV
357
Fiserv Inc
FISV
$28.9B
$385K 0.02%
+13,576
New +$388K
NJR icon
358
New Jersey Resources
NJR
$5.53B
$376K 0.02%
+15,106
New +$347K
VYX icon
359
NCR Voyix
VYX
$1.16B
$373K 0.02%
+16,626
New +$353K
FNSR
360
DELISTED
Finisar Corp
FNSR
$373K 0.02%
+14,081
New +$338K
HSY icon
361
Hershey
HSY
$36.8B
$368K 0.02%
+3,524
New +$360K
SNMX
362
DELISTED
Senomyx, Inc.
SNMX
$362K 0.02%
+33,957
New +$284K
MNST icon
363
Monster Beverage
MNST
$92.1B
$355K 0.02%
30,654
-35,346
-54% -$413K
CPN
364
DELISTED
Calpine Corporation
CPN
$355K 0.02%
17,000
+3,500
+26% +$68.6K
GPRE icon
365
Green Plains
GPRE
$1.06B
$347K 0.02%
+11,570
New +$284K
ATVI
366
DELISTED
Activision Blizzard
ATVI
$347K 0.02%
+16,992
New +$323K
JACK icon
367
Jack in the Box
JACK
$331M
$336K 0.02%
5,700
-7,425
-57% -$405K
PLX icon
368
Protalix BioTherapeutics
PLX
$197M
$334K 0.02%
+7,300
New +$341K
TDAY
369
USA Today Co
TDAY
$1.17B
$333K 0.02%
+22,200
New +$311K
ROC
370
DELISTED
ROCKWOOD HLDGS INC
ROC
$327K 0.02%
+4,400
New +$324K
ZLC
371
CALL
DELISTED
ZALE CORPORATION
ZLC
$324K 0.02%
+15,500
New +$281K
AA icon
372
PUT
Alcoa
AA
$12.5B
$322K 0.02%
+10,404
New +$289K
MSI icon
373
Motorola Solutions
MSI
$78.5B
$322K 0.02%
+5,010
New +$327K
WAT icon
374
Waters Corp
WAT
$39.2B
$322K 0.02%
+2,968
New +$322K
BALL icon
375
Ball Corp
BALL
$16.7B
$320K 0.02%
+11,664
New +$309K

Similar funds

BlueCrest Capital Management (UK)'s Q1 2014 Portfolio in Review

As of Q1 2014, BlueCrest Capital Management (UK) held 682 positions worth $1.77B, up 46% from $1.22B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

BlueCrest Capital Management (UK) deployed $300M of net new capital in Q1 2014, opening 309 new positions and adding to 98 existing holdings. Its largest new stake was Yellow Corporation Common Stock: 1,242,084 shares worth $27.9M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, up from 9.3% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Medtronic, an estimated $9.5M trimmed.

  • BlueCrest Capital Management (UK)'s largest Q1 2014 buy was Yellow Corporation Common Stock: 1,242,084 shares worth $27.9M.
  • BlueCrest Capital Management (UK) added most to RTX Corp in Q1 2014, an estimated $27.3M increase.
  • BlueCrest Capital Management (UK)'s biggest Q1 2014 reduction was Medtronic, cutting an estimated $9.5M.
  • BlueCrest Capital Management (UK) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $91.8M.
  • BlueCrest Capital Management (UK)'s ten largest holdings make up 28% of its $1.77B portfolio in Q1 2014.
  • BlueCrest Capital Management (UK) opened 309 new positions and closed 186 in Q1 2014.
  • BlueCrest Capital Management (UK)'s portfolio value rose 46% quarter-over-quarter to $1.77B.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q1 2014, filed 15 May 2014.